SurgLine International, Inc.
SGLN · OTC
7/31/2012 | 4/30/2012 | 1/31/2012 | 10/31/2011 | |
|---|---|---|---|---|
| Market Cap | $2,673 | $2,139 | $7,564 | $7,991 |
| - Cash | $7 | $15 | $9 | $10 |
| + Debt | $376 | $575 | $577 | $603 |
| Enterprise Value | $3,042 | $2,699 | $8,131 | $8,584 |
| Revenue | -$6 | $16 | $28 | $75 |
| % Growth | -134.6% | -42.6% | -63% | – |
| Gross Profit | -$13 | $10 | $6 | $36 |
| % Margin | 231.2% | 63.5% | 21.2% | 47.6% |
| EBITDA | -$520 | -$47 | -$147 | -$1,733 |
| % Margin | 9,387.7% | -296.1% | -527.4% | -2,302.4% |
| Net Income | -$255 | -$173 | -$510 | -$1,801 |
| % Margin | 4,597.8% | -1,078.2% | -1,827.9% | -2,392.3% |
| EPS Diluted | -0 | -0 | -0 | -0.01 |
| % Growth | -47.5% | 67.7% | 99% | – |
| Operating Cash Flow | -$34 | -$50 | -$157 | -$116 |
| Capital Expenditures | $0 | $0 | -$1 | -$1 |
| Free Cash Flow | -$33 | -$50 | -$158 | -$117 |